These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36558325)

  • 1. Preclinical PET and MR Evaluation of
    Winter G; Eberhardt N; Löffler J; Raabe M; Alam MNA; Hao L; Abaei A; Herrmann H; Kuntner C; Glatting G; Solbach C; Jelezko F; Weil T; Beer AJ; Rasche V
    Nanomaterials (Basel); 2022 Dec; 12(24):. PubMed ID: 36558325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, radiolabeling, and preclinical in vivo evaluation of
    Wanek T; Mairinger S; Raabe M; Alam MNA; Filip T; Stanek J; Winter G; Xu L; Laube C; Weil T; Rasche V; Kuntner C
    Nucl Med Biol; 2023; 116-117():108310. PubMed ID: 36565646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of nanoScan PET/CT and PET/MR for quantitative imaging of
    Chomet M; Schreurs M; Vos R; Verlaan M; Kooijman EJ; Poot AJ; Boellaard R; Windhorst AD; van Dongen GA; Vugts DJ; Huisman MC; Beaino W
    EJNMMI Res; 2021 Jun; 11(1):57. PubMed ID: 34117946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers.
    Xu J; Cai F; Luo Z; Fan W; Dai J; Cui J; Li S; Geng C; Zheng Q; Wang Z; Tang X
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2618-2633. PubMed ID: 35347438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Characterization of
    Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Starmans LWE; Hummelink MAPM; Rossin R; Kneepkens ECM; Lamerichs R; Donato K; Nicolay K; Grüll H
    Adv Healthc Mater; 2015 Oct; 4(14):2137-2145. PubMed ID: 26333024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specifically labeled
    Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
    Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalization of
    Wanek T; Raabe M; Alam MNA; Filip T; Stanek J; Loebsch M; Laube C; Mairinger S; Weil T; Kuntner C
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total-Body PET and Highly Stable Chelators Together Enable Meaningful
    Berg E; Gill H; Marik J; Ogasawara A; Williams S; van Dongen G; Vugts D; Cherry SR; Tarantal AF
    J Nucl Med; 2020 Mar; 61(3):453-460. PubMed ID: 31562219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
    Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
    J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    Bauman A; Valverde IE; Fischer CA; Vomstein S; Mindt TL
    J Nucl Med; 2015 Oct; 56(10):1569-74. PubMed ID: 26251418
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Privé BM; Derks YHW; Rosar F; Franssen GM; Peters SMB; Khreish F; Bartholomä M; Maus S; Gotthardt M; Laverman P; Konijnenberg MW; Ezziddin S; Nagarajah J; Heskamp S
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2064-2076. PubMed ID: 34932154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
    Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
    Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.
    Gholami YH; Yuan H; Wilks MQ; Maschmeyer R; Normandin MD; Josephson L; El Fakhri G; Kuncic Z
    Int J Nanomedicine; 2020; 15():1253-1266. PubMed ID: 32161456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing
    Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ
    Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    England CG; Ehlerding EB; Hernandez R; Rekoske BT; Graves SA; Sun H; Liu G; McNeel DG; Barnhart TE; Cai W
    J Nucl Med; 2017 Jan; 58(1):162-168. PubMed ID: 27493273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.